Agreed. Low OS, decreasing short interest, increasing institutional ownership, and the "whopping" market cap is setting up for a big move.
Sunday the company will release ARVO data. Next Tuesday is the biotech summit. 2 weeks from tomorrow is earnings. A lot happening in the next two weeks. Is the Friday NASDAQ compliance a coincidence?